🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsStructure-activity relationships of GLP-1 analogs — anyone have experience? Page 5

Structure-activity relationships of GLP-1 analogs — anyone have experience?

sarah_TO Sun, Aug 4, 2024 at 10:31 PM 32 replies 1,968 viewsPage 5 of 7
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Aug 5, 2024 at 5:36 AM#21

Congrats sarah_TO!! You should be so proud of yourself. 🎉

Last edited: Aug 5, 2024 at 9:36 AM
48 23wanda_boise, NurseAsh_DET, BenResearch_OR and 45 others
Reply Quote Save Share Report
fiona_VT
Member
178
890
Dec 2024
Vermont
Aug 5, 2024 at 5:53 AM#22

Reading this thread on Structure-activity hits close to home. Dad of 2 checking in — I started at 293 lbs and felt like I would tried everything.

9 months on tirz and I am a different person. Not just the 68 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Structure-activity — take the leap. It was the best health decision I have ever made. ❤️

4 15hans_munich, jason_sac26, chris_chi24 and 1 other
Reply Quote Save Share Report
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Aug 5, 2024 at 6:10 AM#23

As a healthcare provider, I want to add some clinical context to this discussion on Structure-activity relationships of.

Building on what maya_sedona said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Aug 5, 2024 at 8:10 AM
25 20paul_denver, TinaHashiRN, robert_kc and 22 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Aug 5, 2024 at 6:27 AM#24

fiona_VT — wow. This community is amazing.

25 17fiona_VT, denise_HTX, raj_cambridge and 22 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Aug 5, 2024 at 6:44 AM#25

Adding my data to this Structure-activity discussion:

MetricBaselineMonth 5Month 8
Weight246 lbs246 lbs221 lbs
A1C7.0%6.0%5.4%
hsCRP5.04.01.2

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.3g/kg/day.

46 3mike_nyc, VendorMark, COA_Karl and 43 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register